COCO/DAND5 inhibits developmental and pathological ocular angiogenesis
Abstract Neovascularization contributes to multiple visual disorders including age‐related macular degeneration (AMD) and retinopathy of prematurity. Current therapies for treating ocular angiogenesis are centered on the inhibition of vascular endothelial growth factor (VEGF). While clinically effec...
| Main Authors: | , , , , , , , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Springer Nature
2021-02-01
|
| 丛编: | EMBO Molecular Medicine |
| 主题: | |
| 在线阅读: | https://doi.org/10.15252/emmm.202012005 |